Tuesday, April 29, 2025 4/29/2025

A computational platform to improve the prioritization of drugs and target genes for therapeutic intervention

Award Number: R44TR002035
ORGANIZATION: NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

Group Awards By:

View Award Description

A computational platform to improve the prioritization of drugs and target genes for therapeutic intervention - Project Summary This project proposes further development of a computational discovery platform shown to quantifiably identify and prioritize both targets and compounds for therapeutic intervention, which will accelerate the development of newer, more effective drugs with fewer side-effects. This platform is based on a novel fusion of two state of the art computational approaches (phenolog mapping and functional networks) with proprietary data from Genetic Networks powerful gene-drug screening assays (H-Tech and Y-Tech) that identify drug targets, conserved drug target pathways, and off-target effects (e.g. toxicity) by genome- wide phenotypic profiling. The computational platform identifies conserved and functionally linked genes to define conserved biological modules, groups of gene that work tightly together and contribute to disease phenotypes and drug responses. The first aim is to improve the throughput and robustness of Genetic Networks computational platform to provide the pharmaceutical industry with a proven tool to select better compounds for their drug development pipelines and clinical trials. The second aim is to improve the prioritization of target genes that will be most effective in treating disease. Many genes have very similar copies, known as paralogs, which can complicate the interpretation of biological data. This project will integrate diverse biological information to prioritize the best gene target based on the disease, the relevant tissue, and how each gene interacts with other genes. The third aim is to identify common groups of genes involved in multiple disease and/or multiple drug responses. Understanding the genes involved in multiple biological processes allows pharmaceutical companies to repurpose already approved drug for new purposes and lowers the cost of developing multiple drugs for multiple disease. In addition, this approach will identify the potential drug interactions that can lead to severe side-effects when drugs are taken together without requiring animal testing or risking patient lives. This automated system will rapidly identify and prioritize therapeutic interventions across multiple diseases and will increase the success rate of drug discovery and provide guidance to repurpose existing drugs for new indications. Implementation of the platform described in this proposal will strengthen Genetic Networks' contributions to the goal of bringing new treatments to patients faster.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2023 ( Subtotal = $0 )
2023	2020	GENETIC NETWORKS, LLC	351 W 46TH ST	MIAMI BEACH	FL	33140	MIAMI-DADE	USA	National Center for Advancing Translational Sciences	000	3	12/19/2022	NON-COMPETING CONTINUATION	$0
														Subtotal = $0

Issue Date FY: 2022 ( Subtotal = $0 )
2022	2020	GENETIC NETWORKS, LLC	351 W 46TH ST	MIAMI BEACH	FL	33140	MIAMI-DADE	USA	National Center for Advancing Translational Sciences	000	3	12/9/2021	NON-COMPETING CONTINUATION	$0
2022	2020	GENETIC NETWORKS, LLC	351 W 46TH ST	MIAMI BEACH	FL	33140	MIAMI-DADE	USA	National Center for Advancing Translational Sciences	001	3	3/18/2022	NON-COMPETING CONTINUATION	$0
														Subtotal = $0

Issue Date FY: 2021 ( Subtotal = $0 )
2021	2020	GENETIC NETWORKS, LLC	351 W 46TH ST	MIAMI BEACH	FL	33140	MIAMI-DADE	USA	National Center for Advancing Translational Sciences	001	3	2/17/2021	NON-COMPETING CONTINUATION	$0
2021	2019	GENETIC NETWORKS, LLC	351 W 46TH ST	MIAMI BEACH	FL	33140	MIAMI-DADE	USA	National Center for Advancing Translational Sciences	000	2	2/16/2021	COMPETING CONTINUATION	$0
														Subtotal = $0

Issue Date FY: 2020 ( Subtotal = $1,201,372 )
2020	2020	GENETIC NETWORKS, LLC	351 W 46TH ST	MIAMI BEACH	FL	33140	MIAMI-DADE	USA	National Center for Advancing Translational Sciences	001	3	7/6/2020	NON-COMPETING CONTINUATION	$974,572
2020	2020	GENETIC NETWORKS, LLC	351 W 46TH ST	MIAMI BEACH	FL	33140	MIAMI-DADE	USA	National Center for Advancing Translational Sciences	000	2	6/2/2020	SUPPLEMENT FOR EXPANSION	$226,800
														Subtotal = $1,201,372

Issue Date FY: 2019 ( Subtotal = $991,290 )
2019	2019	GENETIC NETWORKS, LLC	351 W 46TH ST	MIAMI BEACH	FL	33140	MIAMI-DADE	USA	National Center for Advancing Translational Sciences	000	2	7/17/2019	COMPETING CONTINUATION	$991,290
														Subtotal = $991,290

Grand Total All Awards = $2,192,662

Top

All Categories

About

Search

Reports

Data Submission

Award Information

A computational platform to improve the prioritization of drugs and target genes for therapeutic intervention

Award Number: R44TR002035

ORGANIZATION: NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer